EquityZen has curated this list of quality resources for secondary investors, shareholders and company representatives.
Have additional questions? We'd love to hear from you.
Chart of the Week - Tech Tumbles Amid Trade Tussles
Concerns over escalating trade tensions with China roiled Wall Street over the past week, with tech shares hit disproportionately hard. The NASDAQ Composite (which is heavily tech-focused) slid 278bps since early last week, underperforming the S&P by ~70bps.
How will the trade concerns impact Silicon Valley investors? Difficult to say at this point as the full scope of trade policy has yet to be finalized and - as is many times the case - the devil is likely to be in the details. Further, unlike public markets where sentiment and expectations are immediately evident, any impact from trade will take time to feed into private valuations given lags between funding rounds. We note some potential ramifications of the new trade initiatives for startups below:
Finance & Research Lead, EquityZen
Cylance - [Cylance Announces $120 Million Funding Round]
Kaleido BioSciences - [Kaleido brings in $101M in series C for its microbiome-wide therapy pipeline]
NGINX - [Nginx Raises $43M in Series C Funding]
Agari - [Agari raises $40 million to grow its AI-powered email authentication platform]
Hired - [Hired raises $30M to build an easy subscription pipeline for company hiring]
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.
Our mission is to improve the way startup employees are paid by unlocking the value of their equity compensation in a way that benefits all key players: the shareholder, the company, and the investor.
Equity securities are offered through EquityZen Securities LLC. Check the background of this firm on FINRA's BrokerCheck.
© 2018 EquityZen Inc. All rights reserved.